EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays

An K Stroobants, Eva-Leonne Göttgens, Yvonne M C Henskens, Joop H Jansen, Saskia E M Schols, Sanna R Rijpma

Haemophilia · 2026-07 · 32 (4) · 1002-1015

DOI: 10.1111/hae.70300 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Haemophilia, online erschienen am 13.05.2026. Verfasst von An K Stroobants und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Factor VIII, Thrombin, Factor IX, Blood Coagulation. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Monitoring extended half‐life (EHL) factor (F) VIII and FIX products is complex, as discrepant results are obtained in different laboratory assays.

Aim

To provide an overview on assay accuracy based on a re‐assessment of previously published data as well as laboratory results of EHL spiking experiments for specific factor assays and thrombin generation (TG).

Methods

Previously published data on specific EHL‐assay combination accuracy were re‐assessed, applying uniform acceptable bias cutoffs at specific factor activity levels. Accuracy of EHL measurement was determined for six routinely used FVIII assays for spiked efmoroctocog alfa and rurioctocog alfa pegol as well as four FIX assays for spiked eftrenonacog alfa, albutrepenonacog alfa and nonacog bèta pegol. TG was performed on these samples to evaluate haemostatic potential.

Results

Re‐assessment of previously published data showed insufficient accuracy for many EHL‐assay combinations. Measurement results of nine previously undescribed EHL‐assay combinations did not meet accuracy criteria for the entire tested factor activity range; results for other EHL‐assay combinations were in many cases comparable to previous reports. TG on spiked efmoroctocog alfa and rurioctocog alfa pegol showed increased peak height (PH) and area under the curve (AUC) at higher factor activity level compared to diluted NPP FVIII. TG of eftrenonacog alfa was comparable to diluted NPP FIX but increased for albutrepenonacog alfa and nonacog bèta pegol.

Conclusion

Accuracy of many routine FVIII or FIX assays is insufficient, and selection of the correct test is essential for producing reliable results. The haemostatic potential of EHL may deviate from the labelled potency according to TG results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIIThrombinFactor IXBlood CoagulationHumansHalf-LifeBlood Coagulation Tests

Stichwörter der Autor:innen

EHLExtended half‐lifeFactor IXFactor VIIIlaboratory testingthrombin generation

Substanzen

Factor VIIIThrombinFactor IX

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc, Nijmegen, the Netherlands.
  • Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, the Netherlands.
  • Department of Laboratory Medicine, Radboudumc Laboratory for Diagnostics, Radboudumc, Nijmegen, The Netherlands.
  • Laboratory For Clinical Chemistry and Hematology, Amphia Hospital, Breda, the Netherlands.
  • Central Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Department of Hematology, Radboudumc, Nijmegen, the Netherlands.

Zitieren

APA

Stroobants, A. K., Göttgens, E. L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300

Vancouver

Stroobants AK, Göttgens EL, Henskens YMC, Jansen JH, Schols SEM, Rijpma SR. Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays. Haemophilia. 2026;32(4):1002-1015. doi:10.1111/hae.70300

BibTeX
@article{Stroobants2026,
  author = {Stroobants, An K and Göttgens, Eva-Leonne and Henskens, Yvonne M C and Jansen, Joop H and Schols, Saskia E M and Rijpma, Sanna R},
  title = {Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {1002--1015},
  doi = {10.1111/hae.70300}
}
Kostenlos starten →